Indirect effect of the COVID-19 pandemic on hospital mortality in patients with hip fracture: a competing risk survival analysis using linked administrative data.

Autor: Grimm F; The Health Foundation, London, UK fiona.grimm@health.org.uk., Johansen A; University Hospital of Wales and Cardiff University School of Medicine, Cardiff, UK.; National Hip Fracture Database, Royal College of Physicians, London, UK., Knight H; The Health Foundation, London, UK., Brine R; The Health Foundation, London, UK., Deeny SR; The Health Foundation, London, UK.
Jazyk: angličtina
Zdroj: BMJ quality & safety [BMJ Qual Saf] 2023 May; Vol. 32 (5), pp. 264-273. Date of Electronic Publication: 2022 Aug 01.
DOI: 10.1136/bmjqs-2022-014896
Abstrakt: Background: Hip fracture is a leading cause of disability and mortality among older people. During the COVID-19 pandemic, orthopaedic care pathways in the National Health Service in England were restructured to manage pressures on hospital capacity. We examined the indirect consequences of the pandemic for hospital mortality among older patients with hip fracture, admitted from care homes or the community.
Methods: Retrospective analysis of linked care home and hospital inpatient data for patients with hip fracture aged 65 years and over admitted to hospitals in England during the first year of the pandemic (1 March 2020 to 28 February 2021) or during the previous year. We performed survival analysis, adjusting for case mix and COVID-19 infection, and considered live discharge as a competing risk. We present cause-specific hazard ratios (HR CS ) for the effect of admission year on hospital mortality risk.
Results: During the first year of the pandemic, there were 55 648 hip fracture admissions: a 5.2% decrease on the previous year. 9.5% of patients had confirmed or suspected COVID-19. Hospital stays were substantially shorter (p<0.05), and there was a higher daily chance of discharge (HR CS 1.40, 95% CI 1.38 to 1.41). Overall hip fracture inpatient mortality increased (7.2% in 2020/2021 vs 6.4% in 2019/2020), but patients without concomitant COVID-19 infection had lower mortality rates compared with the year before (5.3%). Admission during the pandemic was associated with a 11% increase in the daily risk of hospital death for patients with hip fracture (HR CS 1.11, 95% CI 1.05 to 1.16).
Conclusions: Although COVID-19 infections led to increases in hospital mortality, overall hospital mortality risk for older patients with hip fracture remained largely stable during the first year of the pandemic.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze: MEDLINE
Externí odkaz: